Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed ClinicalTrials.gov revision/version updates from **v3.5.2** to **v3.5.3** without changing study details.
    Difference
    0.1%
    Check dated 2026-04-25T05:28:48.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:48:10.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T07:15:37.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:23:21.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page now includes an additional condition keyword 'Fallopian tube cancer' and a new resource link to the Genetic and Rare Diseases Information Center. The page revision is updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T02:25:20.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page shows a revision from v3.4.0 to v3.4.1, indicating a backend/template update. No study data, eligibility criteria, or results are altered, and To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:38:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.